profile picture
Charles Mbata
I'm working on
4 months ago
We’ve built an AI-driven healthcare and biotech platforms for clinical research, objective , and programmable therapeutics. MyMonitor.ai transforms skin images into objective medical data, while MetalDrug advances deterministic therapeutic infrastructure for biotech and pharma.
I'm looking for
4 months ago
Seeking strategic partnerships with healthcare systems, pharma/biotech companies, CROs, academia, and innovation teams for healthcare AI validation, clinical trial modernization, dermatology infrastructure, programmable therapeutics, pilot programs, and enterprise deployment.
About
Founder & CEO of MyMonitor.ai and Co-Founder of MetalDrug, focused on AI-driven healthcare, clinical research modernization, and programmable therapeutics. Expert Clinical Research Associate with experience supporting trials and operations involving Novartis, Amgen, and Syneos Health. MyMonitor.ai is developing melanin-aware clinical workflow infrastructure that transforms skin images into objective medical data for dermatology and clinical trials. Active collaborations include Temple University and Worcester Polytechnic Institute (WPI). PACT Healthcare Advisory Board Member, MeHI Finalist, NSF I-Corps participant, and Nasdaq Milestone Makers Spring 2026 Cohort member focused on scalable healthcare innovation and translational commercialization.
profile picture
Charles Mbata
Work experience
Partner
2025 - Present
Metal Drug
Partner
2024 - Present
Novartis
Expert Clinical Research Associate
2016 - 2024
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Not enough data yet.
Results may appear later and can be imperfect.
Last updated May 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.